EyePoint
EYPT

EyePoint (EYPT) analyst forecast and price target

Analyst forecast

Buy

Consensus of 13 analyst ratings

Buy
8
Hold
5
Sell
0
Average price target
$28.13+527.09% vs. last price
Last $4.49
Low $5.00High $68.00

Based on 8 analyst targets

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.DowngradedBuy → NeutralAug 18, 2026
Chardan CapitalDowngradedBuy → Neutral$5.00 from $65.00Aug 18, 2026
RBC CapitalDowngradedOutperform → Sector Perform$5.00 from $37.00Aug 18, 2026
CitigroupMaintainedBuy$17.00 from $35.00Aug 18, 2026
Chardan CapitalMaintainedBuy$65.00Aug 17, 2026
JefferiesMaintainedBuy$8.00 from $30.00Aug 17, 2026
JP MorganDowngradedOverweight → NeutralAug 17, 2026
Chardan CapitalMaintainedBuy$65.00Aug 7, 2026
HC Wainwright & Co.MaintainedBuy$27.00 from $30.00Aug 6, 2026
Cantor FitzgeraldMaintainedOverweight$55.00 from $47.00Aug 6, 2026
StifelInitiated CoverageBuy$40.00Jul 16, 2026
Cantor FitzgeraldInitiated CoverageOverweight$47.00Jul 8, 2026
Chardan CapitalMaintainedBuy$65.00 from $29.00Jul 1, 2026
GuggenheimMaintainedBuy$68.00Jun 24, 2026
RBC CapitalMaintainedOutperform$37.00 from $39.00May 7, 2026
CitigroupMaintainedBuy$35.00 from $31.00Mar 9, 2026
HC Wainwright & Co.MaintainedBuy$30.00 from $23.00Mar 5, 2026
Chardan CapitalMaintainedBuy$29.00 from $27.00Mar 4, 2026
RBC CapitalMaintainedOutperform$39.00 from $28.00Nov 6, 2025
Chardan CapitalMaintainedBuy$27.00Aug 7, 2025

Frequently asked questions

  • What is the price target for EYPT stock?

    The average 12-month analyst price target for EyePoint (EYPT) is $28.13, with a high estimate of $68.00 and a low of $5.00, across 8 analysts.

  • Is EYPT a buy, sell, or hold?

    Analysts covering EyePoint currently average a Buy rating: 8 buy, 5 hold and 0 sell, from 13 analysts. Ratings reflect analyst opinion, not investment advice.

  • What upside do analysts see for EYPT?

    The average price target of $28.13 implies 527.09% upside from the last price of $4.49.

  • What is the latest analyst rating on EYPT?

    On Aug 18, 2026, HC Wainwright & Co. downgraded EyePoint to Neutral.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.